Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer and inflammatory diseases. In particular, our company utilizes cutting-edge science to develop next-generation therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs.
The company, founded by Dr. Raphael R Pinaud in 2020, has significantly grown and successfully advanced its mission to date. Furthermore, Antharis strategically acquired Cassyni Biopharma and Galileo Biotech, in mid-2022 and mid-2023, respectively, to further and more effectively advance its mandate to bring transformational therapies to patients in need.
Antharis has built an extensive pipeline of innovative therapies and, through pioneering research, is poised to initiate clinical trials in 2025 with several of its assets, making significant strides toward addressing unmet oncology needs.
Company Details
- Employees
- 19
- Founded
- -
- Address
- San Diego, Ca 92081, Us
- Industry
- Biotechnology
- Keywords
- antibodies, therapies, antibody drug conjugates, therapeutic antibodies, monoclonal antibodies, neurology, cancer, oncology, cancer biology, biotechnology, biotech, pharmaceutical, biopharma, breast cancer, bispecific antibodies, pan cancer, colorectal cancer, brain cancer, lymphoma, leukemia, solid tumor.
- HQ
- San Diego, CA
Antharis Therapeutics, Inc. Questions
Antharis Therapeutics, Inc.'s website is http://www.antharistherapeutics.com
Antharis Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/antharis-therapeutics
Antharis Therapeutics, Inc. has
19 employees.
View email and phone details for 19
employees at Antharis Therapeutics, Inc..
Antharis Therapeutics, Inc.'s industry is
Biotechnology
Antharis Therapeutics, Inc.'s top competitors are
Aeterna Therapeutics,
Cassyni Biopharma,
Phanes Therapeutics, Inc.,
Receptabio,
Artiva Biotherapeutics,
Neurocrine Biosciences,
Galileo Biotech,
Avidity Biosciences, Inc.,
Crain,
Biolegend.
Antharis Therapeutics, Inc.'s categories are Biotechnology
Antharis Therapeutics, Inc.'s founding year is 2020
